Novavax Announces Topline RSV F Vaccine Data from Two Clinical Trials in Older Adults
/
Date15 Sep 2016
Topline data from the Resolve™ Phase 3 trial did not meet pre-specified efficacy objectives The attack rate for the Phase 3 primary objective was approximately... Read More →
Healthix Engages Verato, Inc. to Enhance Patient Matching and Linking within their HIE Platform
/
Date15 Sep 2016
NEW YORK, Sept. 15, 2016 (GLOBE NEWSWIRE) — Healthix, the largest public health information exchange (HIE) in the nation, today announced that it has engaged... Read More →
SelfMade Health Network Partners with Meharry Medical College to Combat Breast Cancer Disparities
/
Date15 Sep 2016
HAMPTON, VA., Sept. 15, 2016 (GLOBE NEWSWIRE) — Reducing advanced stage female breast cancer is one of the Office of Disease Prevention and Health Promotion... Read More →
Fidelis Care Celebrates Opening of New, Expanded Office
/
Date15 Sep 2016
FAIRPORT, N.Y., Sept. 15, 2016 (GLOBE NEWSWIRE) — As a reflection of Fidelis Care’s growth and expansion in the Rochester Region, Fidelis Care celebrated the... Read More →
MailMyPrescriptions.com Raises $1.6 Million in Seed Round
/
Date15 Sep 2016
BOCA RATON, Fla., Sept. 15, 2016 (GLOBE NEWSWIRE) — MailMyPrescriptions.com, the nation’s first wholesale pharmacy network, today announced that it has secured $1.6 million in... Read More →
Nevada Population Health Study to Offer Free 23andMe Genetic Tests to Community
/
Date15 Sep 2016
RENO, Nev., Sept. 15, 2016 (GLOBE NEWSWIRE) — Nevada-based Renown Health and the Desert Research Institute (DRI) are collaborating with 23andMe, a leading personal genetics... Read More →
Zappix Visual IVR Adds Flexible Drag and Drop API Support for Integration with CRM and BackOffice Systems
/
Date15 Sep 2016
BOSTON, Mass., Sept. 15, 2016 (GLOBE NEWSWIRE) — via PRWEB – Zappix, the innovative smartphone Visual IVR provider, announced today that it its mobile software... Read More →
Celsion Corporation Announces Positive DSMB Review of Phase 1b OVATION Study in Ovarian Cancer
/
Date15 Sep 2016
LAWRENCEVILLE, N.J., Sept. 15, 2016 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ:CLSN) today announced that the independent Data Safety Monitoring Board (DSMB) has completed its safety review... Read More →
Alleviating Disparities in Clinical Trials
/
Date15 Sep 2016
HAMPTON, Va., Sept. 15, 2016 (GLOBE NEWSWIRE) — Clinical trials are often associated with the “guinea pig” mentality, especially among the elderly, racial and ethnic... Read More →
Aeglea BioTherapeutics Doses First Patients in Phase 1 Trial of AEB1102 for the Treatment of Arginase I Deficiency
/
Date15 Sep 2016
AUSTIN, Texas, Sept. 15, 2016 (GLOBE NEWSWIRE) — Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino... Read More →